TELA Bio reports second quarter 2024 financial results and reiterates full year 2024 revenue guidance

Posted on August 12, 2024 by Vaseline

MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on delivering innovative solutions for soft tissue reconstruction, today reported financial results for the second quarter ended June 30, 2024.

Recent highlights

Related Posts

Mouser Electronics Has Developed Smart Grid Innovations in the New Sector Content Series Page 1

“Rote Rosen” on MDR on livestream and TV: episode 1256 from Staffel 8 der Telenovela

Special transport arrests drunk driver